Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/17480
Guillain-Barre syndrome as the first manifestation of SARS-CoV-2 infection
Identifiers
ISSN: 0213-4853
eISSN: 1578-1968
WOS ID: 000591762900033
Scopus EID: 2-s2.0-85090486081
PMID: 32891435
Embase PUI: L2007685107
Metrics
Share
Export
External links
Statistics
Item usage statisticsMetadata
Show Dublin Core item record
Publication date
2020-11Document type
letter to the editorCitation
Barrachina-Esteve O, Palau Dominguez A, Hidalgo-Torrico I, Viguera Martinez ML. Guillain-Barre syndrome as the first manifestation of SARS-CoV-2 infection [letter]. Neurologia. 2020 Nov;35(9):710-2. Epub 2020 Jul 16.Publisher version
https://dx.doi.org/10.1016/j.nrl.2020.07.001MeSH
Guillain-Barre SyndromeDrug Combinations
SARS-CoV-2
Ceftriaxone
Humans
Hydroxychloroquine
Lopinavir
Middle Aged
Pandemics
Male
Female
Azithromycin
Ritonavir
COVID-19
DeCS
AzitromicinaRitonavir
Síndrome de Guillain-Barré
Femenino
Lopinavir
COVID-19
Masculino
Hidroxicloroquina
Ceftriaxona
Combinación de Medicamentos
Humanos
Persona de Mediana Edad
SARS-CoV-2
Pandemias
This item appears in following Docusalut collections
Hospital Universitario Son Espases - HUSE > Comunicación científica
This item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International